Nymox Pharmaceutical New U.K. Deal For NicAlert(TM) Product

HASBROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--Jan. 11, 2006--Nymox Pharmaceutical Corporation (NASDAQ:NYMX) announced today that it has entered into an agreement with g-Nostics Ltd in the U.K. for the sale and marketing of Nymox’s NicAlert(TM). NicAlert(TM) provides a proven, easy-to-use, on-site means of determining an individual’s level of tobacco product use of or exposure. The product gives a visual read-out of the level of tobacco use or exposure within minutes and requires no instruments to use. NicAlert(TM) received clearance from the U.S. FDA for determining smoking status for medical purposes.

MORE ON THIS TOPIC